Literature DB >> 8034720

Mutagenesis study at a postulated hydrophobic region near the active site of aromatase cytochrome P450.

D Zhou1, L L Cam, C A Laughton, K R Korzekwa, S Chen.   

Abstract

Aromatase, a cytochrome P450, catalyzes three consecutive hydroxylation reactions converting C19 androgens to aromatic C18 estrogenic steroids. On the basis of a recent computer modeling of the active site of aromatase, a hydrophobic pocket, thought to be important for the binding of some aromatase inhibitors, was predicted to extend roughly in the plane of the steroid substrate, from the position that would be occupied by its C4 and C7 atoms. Four mutants, G121A, I125N, F235N, and I474F, were generated to test this model. Although the mutagenesis results have shown that the current model for the active site of aromatase almost certainly contains a number of errors, the results are in general very satisfactory in that they suggest how the model should be altered by local realignments of the aromatase sequence with that of cytochrome P450cam. Among the mutants, I474F is the most interesting one. Its Km value for androstenedione was found to be lower than the wild type enzyme, and the kinetic analysis exhibited a substrate inhibition-like kinetic profile through an "in-cell" assay. In addition, this mutation reduces the binding affinity of an aromatase inhibitor, 4-hydroxyandrostenedione, and increases the binding affinity of two aromatase inhibitors, aminoglutethimide and CGS 16949. This study demonstrates a useful approach, by a combination of computer modeling, site-directed mutagenesis, and inhibitor binding studies, to examine the structure of the active site of aromatase and the binding nature of various aromatase inhibitors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8034720

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  A three-dimensional model of aromatase cytochrome P450.

Authors:  S Graham-Lorence; B Amarneh; R E White; J A Peterson; E R Simpson
Journal:  Protein Sci       Date:  1995-06       Impact factor: 6.725

2.  Comparative molecular field analysis of non-steroidal aromatase inhibitors related to fadrozole.

Authors:  M Recanatini
Journal:  J Comput Aided Mol Des       Date:  1996-02       Impact factor: 3.686

3.  Human and quail aromatase activity is rapidly and reversibly inhibited by phosphorylating conditions.

Authors:  Thierry D Charlier; Nobuhiro Harada; Jacques Balthazart; Charlotte A Cornil
Journal:  Endocrinology       Date:  2011-09-13       Impact factor: 4.736

4.  Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors.

Authors:  T I Oprea; A E García
Journal:  J Comput Aided Mol Des       Date:  1996-06       Impact factor: 3.686

5.  Structural basis for the functional roles of critical residues in human cytochrome p450 aromatase.

Authors:  Jessica Lo; Giovanna Di Nardo; Jennifer Griswold; Chinaza Egbuta; Wenhua Jiang; Gianfranco Gilardi; Debashis Ghosh
Journal:  Biochemistry       Date:  2013-08-16       Impact factor: 3.162

6.  X-ray structure of human aromatase reveals an androgen-specific active site.

Authors:  Debashis Ghosh; Jennifer Griswold; Mary Erman; Walter Pangborn
Journal:  J Steroid Biochem Mol Biol       Date:  2009-10-04       Impact factor: 4.292

7.  Novel aromatase inhibitors by structure-guided design.

Authors:  Debashis Ghosh; Jessica Lo; Daniel Morton; Damien Valette; Jingle Xi; Jennifer Griswold; Susan Hubbell; Chinaza Egbuta; Wenhua Jiang; Jing An; Huw M L Davies
Journal:  J Med Chem       Date:  2012-09-24       Impact factor: 7.446

8.  Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis study.

Authors:  Y C Kao; C Zhou; M Sherman; C A Laughton; S Chen
Journal:  Environ Health Perspect       Date:  1998-02       Impact factor: 9.031

Review 9.  Rapid modulation of aromatase activity in the vertebrate brain.

Authors:  Thierry D Charlier; Charlotte A Cornil; Jacques Balthazart
Journal:  J Exp Neurosci       Date:  2013-07-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.